The Optical Security and Performance Products (OSP) business segment of Viavi Solutions leverages its core strengths in opticas and materials technology to manage light and color effects. With over six decades of experience in optical coating technology, Viavi provides innovative optical security and commercial products targeted to consumers in the consumer electronics, government, automotive, healthcare, and anti-counterfeiting markets.
Miniature near infrared spectroscopy
NIR Sensor solutions for Process Analytical Technology (PAT) and Quality by Design (QbD)
Bandpass filters for non-dispersive spectroscopy
Pharmaceutical
Food
Feed
Agriculture
Healthcare
Market
Chemicals
Defense and Security
Built upon Viavi's proprietary Linear Variable Filter technology, the MicroNIR family of spectrometers are fully integrated, ultra-compact NIR sensors.The MicroNIR is offered in ruggedized handheld models and stainless steel PAT manufacturing models to suit your specific needs. MicroNIR spectrometers are ideal for pharmaceutical and agricultural applications, as well as feed analysis and food diagnostics. Viavi is proud to offer a variety of innovative accessories to optimize the performance of the MicroNIR spectrometer and maximize the success of your near infrared applications.
1402 Mariner Way
Santa Rosa, CA 95407
TELEPHONE
(707) 545-6440
FAX
(707) 525-7028
OSPCustomerservice@viavisolutions.com
WEB SITE
www.viavisolutions.com/micronir
NUMBER OF EMPLOYEES
US: 500
Elsewhere: 150
YEAR FOUNDED
1948
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.